Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Clinical trial NCT02645864 · COMPLETED
Trial details
- NCT number
- NCT02645864
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.